ArticleCancer immunology, immunotherapy : CII2026

Metformin drives HIF-1α-mediated dual metabolic reprogramming to enhance γδ T cell therapy in triple-negative breast cancer.

Xuping Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.